Matches in Wikidata for { <http://www.wikidata.org/entity/Q84788192> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q84788192 description "article scientifique publié en 2012" @default.
- Q84788192 description "artículu científicu espublizáu n'agostu de 2012" @default.
- Q84788192 description "scientific article published on 14 August 2012" @default.
- Q84788192 description "wetenschappelijk artikel" @default.
- Q84788192 description "наукова стаття, опублікована в серпні 2012" @default.
- Q84788192 name "Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect" @default.
- Q84788192 name "Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect" @default.
- Q84788192 type Item @default.
- Q84788192 label "Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect" @default.
- Q84788192 label "Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect" @default.
- Q84788192 prefLabel "Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect" @default.
- Q84788192 prefLabel "Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect" @default.
- Q84788192 P1433 Q84788192-00E81AF6-63F6-436D-B439-5218089A4856 @default.
- Q84788192 P1476 Q84788192-C74B2AFA-D445-4914-8805-2A05E58FCFBF @default.
- Q84788192 P2093 Q84788192-0E6E507C-EF59-4ABE-A307-DBFB788BCCB0 @default.
- Q84788192 P2093 Q84788192-50ADBB15-BC93-4C63-A4CF-168651F811DC @default.
- Q84788192 P2860 Q84788192-68890DC0-7765-4661-8BF8-011D615C316D @default.
- Q84788192 P2860 Q84788192-B3BD4763-AE03-4F85-8D4A-C129EB8C1E0B @default.
- Q84788192 P2860 Q84788192-BE391FDF-5EEC-4F6F-B956-37C0284A5411 @default.
- Q84788192 P2860 Q84788192-CC495617-B49E-45A5-9AB4-AA9B032F78AE @default.
- Q84788192 P2860 Q84788192-CE054E60-740D-4A2D-818D-758FCBF6E671 @default.
- Q84788192 P2860 Q84788192-D9B239AA-A4AC-421F-8847-C291CFCDC79D @default.
- Q84788192 P2860 Q84788192-E5902BC1-91F4-4BD1-95AA-A63E0FBA5BAE @default.
- Q84788192 P304 Q84788192-EB30305C-E3EA-4CF0-8351-C6943C0551C0 @default.
- Q84788192 P31 Q84788192-280266D0-C08D-458C-85BA-D1957507D960 @default.
- Q84788192 P356 Q84788192-139923D2-AF44-4187-B3C8-3AF0C960A912 @default.
- Q84788192 P433 Q84788192-D77226D7-D60C-4E6B-B33E-47371B1F0EF8 @default.
- Q84788192 P478 Q84788192-D96A07E1-7CD3-4A8B-981E-11541E05A884 @default.
- Q84788192 P577 Q84788192-E1DABA14-4C3E-4A79-8C0F-3F1C79D97954 @default.
- Q84788192 P698 Q84788192-5EA9DD6A-6DD6-4413-B08D-96E69E989775 @default.
- Q84788192 P356 NRCLINONC.2012.138 @default.
- Q84788192 P698 22889973 @default.
- Q84788192 P1433 Q641640 @default.
- Q84788192 P1476 "Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect" @default.
- Q84788192 P2093 "Hussein A Tawbi" @default.
- Q84788192 P2093 "John M Kirkwood" @default.
- Q84788192 P2860 Q24594790 @default.
- Q84788192 P2860 Q24631953 @default.
- Q84788192 P2860 Q27851801 @default.
- Q84788192 P2860 Q27860458 @default.
- Q84788192 P2860 Q27860760 @default.
- Q84788192 P2860 Q29614756 @default.
- Q84788192 P2860 Q33384029 @default.
- Q84788192 P304 "496-497" @default.
- Q84788192 P31 Q13442814 @default.
- Q84788192 P356 "10.1038/NRCLINONC.2012.138" @default.
- Q84788192 P433 "9" @default.
- Q84788192 P478 "9" @default.
- Q84788192 P577 "2012-08-14T00:00:00Z" @default.
- Q84788192 P698 "22889973" @default.